Accumulation of methotrexate polyglutamates in lymphoblasts is a determinant of antileukemic effects in vivo. A rationale for high-dose methotrexate.

Methotrexate (MTX) is one of the most widely used drugs for the treatment of childhood acute lymphoblastic leukemia (ALL) and is commonly given in high doses. However, the rationale for high-dose MTX (HDMTX) has been challenged recently. To determine whether higher MTX polyglutamate (MTXPG) concentr...

ver descrição completa

Detalhes bibliográficos

Publicado no:	J Clin Invest
Principais autores:	Masson, E, Relling, M V, Synold, T W, Liu, Q, Schuetz, J D, Sandlund, J T, Pui, C H, Evans, W E
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Clinical Investigation 1996
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC507064/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8550853/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI118409
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!